Lee EJ - Search Results

1

Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.

Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, Gu F, Auchus R, Leelawattana R, Lee EJ, Kim JH, Lacroix A, Laplanche A, O'Connell P, Tauchmanova L, Pedroncelli AM, Biller BMK; LINC 3 investigators. Pivonello R, et al. Among authors: lee ej. Lancet Diabetes Endocrinol. 2020 Sep;8(9):748-761. doi: 10.1016/S2213-8587(20)30240-0. Epub 2020 Jul 27. Lancet Diabetes Endocrinol. 2020. PMID: 32730798 Clinical Trial.

2

Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea.

Hur KY, Kim JH, Kim BJ, Kim MS, Lee EJ, Kim SW. Hur KY, et al. Among authors: lee ej. Endocrinol Metab (Seoul). 2015 Mar 27;30(1):7-18. doi: 10.3803/EnM.2015.30.1.7. Endocrinol Metab (Seoul). 2015. PMID: 25827452 Free PMC article. Review.

3

Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults.

Ku CR, Brue T, Schilbach K, Ignatenko S, Magony S, Chung YS, Kim BJ, Hur KY, Kang HC, Kim JH, Kim MS, Kowalska A, Bolanowski M, Ruchala M, Damjanovic S, Payer J, Choi YJ, Heo SJ, Kim TK, Heo M, Lee J, Lee EJ. Ku CR, et al. Among authors: lee ej, lee j. Eur J Endocrinol. 2018 Sep;179(3):169-179. doi: 10.1530/EJE-18-0185. Epub 2018 Jul 4. Eur J Endocrinol. 2018. PMID: 29973375 Clinical Trial.

4

Prolactin ≤1 ng/mL predicts macroprolactinoma reduction after cabergoline therapy.

Kim D, Ku CR, Kim K, Jung H, Lee EJ. Kim D, et al. Among authors: lee ej. Eur J Endocrinol. 2020 Feb;182(2):177-183. doi: 10.1530/EJE-19-0753. Eur J Endocrinol. 2020. PMID: 31770105

5

Gene therapy of pituitary diseases.

Lee EJ, Jameson JL. Lee EJ, et al. J Endocrinol. 2005 Jun;185(3):353-62. doi: 10.1677/joe.1.06023. J Endocrinol. 2005. PMID: 15930161 Review.

6

The adaptation and relationship of FGF-23 to changes in mineral metabolism in Graves' disease.

Park SE, Cho MA, Kim SH, Rhee Y, Kang ES, Ahn CW, Cha BS, Lee EJ, Kim KR, Lee HC, Lim SK. Park SE, et al. Among authors: lee ej, lee hc. Clin Endocrinol (Oxf). 2007 Jun;66(6):854-8. doi: 10.1111/j.1365-2265.2007.02824.x. Epub 2007 Apr 15. Clin Endocrinol (Oxf). 2007. PMID: 17437520

7

Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.

Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ. Cho MA, et al. Among authors: lee ej, lee hc, lee mk, lee jh. J Endocrinol. 2007 Nov;195(2):255-63. doi: 10.1677/JOE-06-0193. J Endocrinol. 2007. PMID: 17951536

8

Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.

Lee Y, Kim JM, Lee EJ. Lee Y, et al. Among authors: lee ej. J Endocrinol. 2008 Nov;199(2):191-9. doi: 10.1677/JOE-08-0250. Epub 2008 Aug 27. J Endocrinol. 2008. PMID: 18753332

9

Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?

Lee EJ, Ahn JY, Noh T, Kim SH, Kim TS, Kim SH. Lee EJ, et al. Neurosurgery. 2009 Mar;64(3 Suppl):ons62-9; discussion ons69-70. doi: 10.1227/01.NEU.0000330406.73157.49. Neurosurgery. 2009. PMID: 19240574

10

Nationwide survey of acromegaly in South Korea.

Kwon O, Song YD, Kim SY, Lee EJ; Rare Disease Study Group, Science and Research Committee, Korean Endocrine Society. Kwon O, et al. Among authors: lee ej. Clin Endocrinol (Oxf). 2013 Apr;78(4):577-85. doi: 10.1111/cen.12020. Clin Endocrinol (Oxf). 2013. PMID: 22909047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,943 results

Search Page